Role of incretin based therapies in the treatment of diabetic kidney disease
Diabetic kidney disease (DKD), a serious microvascular complication of diabetes mellitus is a leading cause of end-stage renal disease and is associated with an increased risk of cardiovascular morbidity and mortality. Despite advancements in blood glucose and blood pressure (BP) control, ~20% to 40...
Enregistré dans:
Auteurs principaux: | Paola Fioretto, Andrea Frascati |
---|---|
Format: | article |
Langue: | EN RU |
Publié: |
Endocrinology Research Centre
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e96ccbff02ea4c3eb6e487f109d992fc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
par: Elena Valer'evna Biryukova
Publié: (2014) -
Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
par: Yury Ivanovich Suntsov
Publié: (2012) -
The role of incretin-based therapies in the management of type 2 diabetes mellitus: perspectives on the past, present and future
par: Juris J. Meier
Publié: (2019) -
Inсretin-based therapy in patients with type 2 diabetes and chronic kidney disease
par: Minara Shamkhalovna Shamkhalova, et autres
Publié: (2012) -
Expert committee on introduction of incretin-based therapy in Russia: advance and failure
par: Editorial team Diabetes Mellitus
Publié: (2012)